News and Announcements
China-based anti-counterfeit App maker YPB Group set for ASX-listing
- Published July 14, 2014 3:26PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Source: The Australian Financial Review; Published: Monday, 14th July 2014
YPB Group, a company that is making a smartphone App to help Chinese consumers spot fakes by authenticating branded products as genuine, has managed to get its plans for a backdoor listing on the Australian Securities Exchange over the line.
The company, which had been seeking to raise up to $6 million by June 30 needed an extension of time but closed the offer on Friday July 11 having secured $3.7 million, pipping the minimum $3 million needed for the float to proceed. A final listing date is yet to be set but it is expected to be before the end of the month.
According to a statement from the company the greater-Asian anti-counterfeit authentication market is currently valued at $US14 billion ($14.91 billion) per annum and growing at a rate of 20 per cent each year.
At listing, the company will have an indicative market capitalisation of just over $20 million.
To view to full article please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
